Seeking Alpha

Shares of AngioDynamics (ANGO +2.4%) were roiled late in the trading day after the company cut...

Shares of AngioDynamics (ANGO +2.4%) were roiled late in the trading day after the company cut its FQ3 and FY revenue forecast and halted shipments of it NanoKnife ablation device in the U.S. due to a software recall. It now sees Q3 sales between $50M - $53M versus estimates of $53M, and 2012 sales of around $215M - $219M compared to expectations of $221M.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|